Which clinical feature best distinguishes Type 1 diabetes from Type 2 diabetes in a newly diagnosed Indian patient?

Explanation

## Distinguishing Type 1 from Type 2 Diabetes ### Key Pathophysiologic Difference **Key Point:** Type 1 diabetes is an autoimmune condition with absolute insulin deficiency due to β-cell destruction, while Type 2 is characterized by insulin resistance with relative insulin deficiency. ### Discriminating Features | Feature | Type 1 | Type 2 | |---------|--------|--------| | **Autoimmune markers** | Anti-GAD, anti-IA2, anti-ZnT8 antibodies present | Absent | | **C-peptide level** | <0.3 ng/mL (severe deficiency) | >0.3 ng/mL (preserved secretion) | | **Insulin secretion** | Absent/minimal | Present but inadequate | | **Age of onset** | Usually <30 years | Usually >40 years | | **Presentation** | Acute, symptomatic | Insidious, often asymptomatic | | **BMI** | Normal to low | Usually elevated | | **Family history** | Less common | Common (60–90%) | ### Why C-Peptide and Antibodies Are Gold Standard **High-Yield:** C-peptide is cleaved from proinsulin during insulin synthesis and reflects endogenous β-cell function. In Type 1, the autoimmune destruction is so complete that C-peptide becomes undetectable (<0.3 ng/mL), whereas in Type 2, residual β-cell function persists (C-peptide >0.3 ng/mL). Anti-islet cell antibodies (anti-GAD65, anti-IA2, anti-ZnT8) are present in 85–90% of Type 1 patients at diagnosis and are virtually absent in Type 2. **Clinical Pearl:** A young, lean patient with acute-onset hyperglycemia and detectable anti-islet antibodies but undetectable C-peptide has Type 1 diabetes. This combination is pathognomonic and distinguishes it from Type 2 in all other respects. ### Why Other Features Are Not Discriminating - **Elevated fasting glucose** (option B): Both types can present with very high glucose levels; not discriminating. - **DKA at presentation** (option C): While more common in Type 1, can occur in Type 2 (especially in acute stress); not a reliable sole discriminator. - **Obesity and metabolic syndrome** (option D): Typical of Type 2 but not present in all cases; Type 1 patients are usually lean but this is not always true.